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Abstract
Background: Modification of teichoic acids with D-alanine by the products of the dlt operon
protects Gram-positive bacteria against major antimicrobial host defense molecules such as
defensins, cathelicidins, myeloperoxidase or phospholipase. The graRS regulatory genes have
recently been implicated in the control of D-alanylation in Staphylococcus aureus.
Results: To determine the impact of the GraRS regulatory system on resistance to antimicrobial
host defense mechanisms and virulence of S. aureus, we compared inactivation of S. aureus SA113
wild type and its isogenic graRS deletion mutant by the human cathelicidin LL-37 or human
neutrophil granulocytes in vitro, and the ability to cause infection in vivo. We show here that graRS
deletion considerably alters bacterial surface charge, increases susceptibility to killing by human
neutrophils or the defense peptide LL-37, and attenuates virulence of S. aureus in a mouse infection
model.
Conclusion: Our results indicate that S. aureus can regulate its surface properties in order to
overcome innate host defenses.
Background
Staphylococcus aureus, a frequent cause of human infec-
tions, is highly resistant to antimicrobial factors of the
innate immune system such as cationic antimicrobial
peptides (CAMPs) [1,2] which are produced by epithelial
cells and neutrophils [3,4]. These peptides generally con-
tain 10–50 amino acids and have positive net charges [5].
Due to their cationic properties, CAMPs can easily bind to
the highly negatively charged bacterial cell envelope and
inactivate bacteria, e.g. by forming pores in the bacterial
membrane leading to bacterial lysis [6]. S. aureus has
evolved mechanisms to alter the anionic charge of cell sur-
face components to gain resistance to a broad variety of
cationic antimicrobial factors such as CAMPs [7], phos-
pholipase A2 [8], myeloperoxidase [9], or lysozyme [10].
One such mechanism is based upon modification of
phospholipids in the cytoplasmic membrane by introduc-
ing a positively charged lysyl group into anionic phos-
phatidylglycerol by the MprF protein, thereby
neutralizing the net charge of the membrane surface
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[11,12]. A similar reaction is mediated by products of the
dltABCD operon, which are responsible for attachment of
positively charged D-alanine residues into negatively
charged phosphate groups in the backbone of teichoic
acids [7,9]. Mechanisms involved in the regulation of
these resistance factors are not yet well understood in
Gram-positive bacteria. Herbert et al. recently found that
the S. aureus two-component regulatory system graRS pos-
itively regulates expression of the dlt operon. In a S. aureus
SA113 graRS deletion mutant, the content of D-alanine in
teichoic acids was reduced by 47% and the mutant
showed reduced resistance to various antibiotics includ-
ing polymyxin B, gallidermin, and vancomycin [10,13].
Accordingly,  graRS have previously been implicated in
regulation of vancomycin intermediary resistance [14]. As
the dlt operon plays a key role in S. aureus resistance to cat-
ionic antimicrobial host molecules, the graRS system may
be important in evasion of host defense mechanisms such
as cationic antimicrobial peptides and neutrophil killing.
Results
The graRS mutant shows altered cell surface charge but 
unaltered lysyl-phosphatidylglycerol (LPG) content
In order to study if reduced expression of the dlt operon
upon  graRS disruption results in altered cell surface
charge, we compared binding of the red-coloured, cati-
onic protein cytochrome c to wild type S. aureus SA113
(WT), the isogenic graRS mutant, and the plasmid-com-
plemented mutant.
The graRS mutant bound significantly more cytochrome c
than the WT or the complemented mutant (Fig. 1A),
which is in accordance with the recently described
reduced content of D-alanine residues in the teichoic
acids of the mutant [10].
To analyse whether increased binding of cytochrome c by
the  graRS mutant is in fact due to altered cell surface
charge by decreased teichoic acid alanylation or the
altered expression of other surface-exposed molecules, we
also examined binding of cytochrome c to a dltA deletion
mutant, which completely lacks D-alanine substitution of
teichoic acids [7], and a dltA/graRS double deletion
mutant, which was generated by transducing the graRS
mutation into the dltA mutant. Due to the high binding
capacities of the dltA and the dltA/graRS mutant we mod-
ified the conditions in order to prevent limitation of
applied cytochrome c. Deletion of the graRS genes in the
dlt mutant background did not lead to further increased
binding of cytochrome c compared to the dltA mutant
(Fig. 1B). This finding indicates that the increased binding
of cytochrome c by the graRS mutant is due to decreased
alanylation of teichoic acids and that the resulting surface
charge alteration does not result from other regulatory
effects mediated by GraRS.
Increased binding of cationic proteins may also result
from reduced mprF expression and, accordingly, reduced
lysylphosphatidylglycerol (LPG) content. To control for
this possibility, we compared patterns of membrane lipids
from log-phase bacteria by thin-layer chromatography.
The amounts of LPG from WT and graRS mutant were
indistinguishable (data not shown), which corroborates
recent findings that mprF is not among the graRS-regu-
lated genes in S. aureus SA113 [10].
The graRS mutant is more susceptible to killing by LL-37 and human 
neutrophil granulocytes in vitro
In an attempt to test whether the increased affinity of the
graRS mutant to cationic molecules leads to higher sus-
ceptibility to human host defense peptides, we compared
inactivation of WT and graRS mutant by the human cathe-
licidin LL-37. This antimicrobial peptide is active against
S. aureus at high concentrations or long exposure [15] but
in this experiment we chose conditions under which the
LL-37 did not affect viability of the S. aureus WT. Accord-
ingly, the WT and complemented mutant strains showed
no significant decrease in CFU following LL-37 exposure,
whereas the number of graRS mutant bacteria recovered
was only 25% of the original inoculum (Fig. 2A).
Next we investigated whether the graRS mutant is killed
faster than the parental strain by human neutrophils,
which produce high amounts of LL-37 and other CAMPs
as components of their antibacterial killing arsenal. The
Binding of cationic cytochrome c (cyt c) by S. aureus Sa113  wild type, graRS mutant, and complemented graRS mutant  (A) and by the dltA mutant and the dltA/graRS double mutant  (B) Figure 1
Binding of cationic cytochrome c (cyt c) by S. aureus 
Sa113 wild type, graRS mutant, and complemented 
graRS mutant (A) and by the dltA mutant and the 
dltA/graRS double mutant (B). Bacteria were incubated 
with 500 μl cytochrome c solution (0.5 mg/ml) (A) or 750 μl 
cytochrome c solution (1 mg/ml) (B). The means and SEM of 
at least three independent experiments are shown. P values < 
0.05 as calculated by Student's t test were regarded statisti-
cally significant.BMC Microbiology 2008, 8:85 http://www.biomedcentral.com/1471-2180/8/85
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graRS mutant was killed by neutrophils considerably
faster than the WT strain. After 15 and 30 min, the recov-
ered CFU of the graRS mutant were significantly lower
than those of the WT (Fig 2B). Of note, our previous stud-
ies had shown that altered alanylation of teichoic acids
does not affect the rate of PMN phagocytosis [9]. Taken
together, these data indicate that graRS-mediated control
of CAMP resistance mechanisms is of importance for S.
aureus evasion from neutrophil killing.
Deletion of graRS leads to attenuated virulence in a mouse infection 
model
To investigate the impact of reduced resistance of the
graRS mutant to neutrophil and CAMP-mediated killing
on the ability of the bacteria to cause infections in vivo, we
compared the virulence of WT and mutant bacteria in a
mouse challenge model. Therefore female BALB/c mice
(12 to 15 weeks old) were infected with S. aureus WT or
graRS mutant bacteria. 72 h after infection numbers of
CFU/kidney were determined.
Significantly less bacteria were detected in the kidneys of
animals, which had been infected with the graRS mutant
than those infected with the WT bacteria. (Fig. 3) This
finding is in coincidence with the increased susceptibility
to clearance by CAMPs and neutrophils, corroborating the
central importance of these host factors in innate defense.
Discussion
A large variety of regulatory systems has been described in
S. aureus during the last decades [16-18]. While many sys-
tems have been shown to control adhesion and toxin pro-
duction [19], much less is known about the regulation of
genes involved in the resistance to antimicrobial peptides,
such as the dlt genes. However, the critical role of this
operon in infection [7,9] suggests that it may be appropri-
ately regulated in response to environmental stimuli. Lis-
teria monocytogenes expresses the VirR transcription factor,
which regulates both the dlt operon and the mprF gene
[20]. The S. aureus regulatory genes rot and arl have previ-
ously been shown to have a moderate influence on tran-
scription of the dlt  operon [21,22]. We have recently
demonstrated that inactivation of the GraRS system leads
to only 13% of the wild-type transcription level of the dlt
operon and a decreased level of teichoic acid alanylation
in S. aureus SA113 [10]. Other important genes regulated
by graRS in S. aureus include the vraFG genes involved in
the resistance to vancomycin [10,13]. Similar data have
recently been presented for the Staphylococcus epidermidis
aps system [23]. This three component regulatory system
is homologous to the graRS system of S. aureus. However,
when initially describing the graRS system in S. aureus,
Meehl et al. failed to recognize the three-component
nature of this system [13]. Li et al. recently showed that
deletion of graS in the community-associated MRSA strain
MW2 leads to decreased minimal inhibitory concentra-
tions of some cationic antimicrobial peptides such as the
human beta-defensin hBD3 or the human cathelicidin LL-
37 and, similar to our studies, to decreased virulence of
the mutant in a mouse infection model [24]. Further-
more, they could show that several important factors in
CAMP resistance including the dlt operon and mprF are
activated by a diverse panel of antimicrobial peptides
[24]. The fact that mprF is not regulated by graRS in S.
aureus SA113 could be due to the deficiency of this strain
in the global gene regulatory system agr [25] or to other
genetic defects.
(A) Inactivation of wild type (black bar), graRS mutant (white  bar) and complemented mutant (grey bar) by LL-37 after 20- min incubation with 20 μg/ml LL-37 Figure 2
(A) Inactivation of wild type (black bar), graRS 
mutant (white bar) and complemented mutant (grey 
bar) by LL-37 after 20-min incubation with 20 μg/ml 
LL-37. (B) Inactivation of wild-type (squares) and mutant 
bacteria (circles) by human neutrophils after 15, 30 and 60 
minutes. The means and SEM of three independent experi-
ments run in duplicate (A) and the means and SD of two 
independent experiments run in duplicate (B) are shown. P 
values < 0.05 as calculated by Student's t test were regarded 
statistically significant.
CFU of wild-type and mutant bacteria in kidneys of mice 72 h  after intraperitoneal infection with 1.2 × 108 bacteria Figure 3
CFU of wild-type and mutant bacteria in kidneys of 
mice 72 h after intraperitoneal infection with 1.2 × 
108 bacteria. For each strain 16 animals were tested. Medi-
ans are given as horizontal lines. A P value < 0.05 as calcu-
lated by Student's t test was regarded statistically significant.BMC Microbiology 2008, 8:85 http://www.biomedcentral.com/1471-2180/8/85
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Conclusion
We could show here that, besides its role in influencing
the effectiveness of pharmacologic antimicrobials, the
GraRS regulatory system plays a key role in resistance to
natural antimicrobials of our innate immune system
against S. aureus and merits further attention in an era of
increasing reports of virulent and drug-resistant strains of
this foremost human pathogen.
Methods
Strains and growth conditions
Staphylococcus aureus SA113 (WT), the isogenic graRS dele-
tion mutant [10], the plasmid-complemented graRS dele-
tion mutant [10], the isogenic dltA deletion mutant [7]
and the isogenic dltA/graRS double deletion mutant were
inoculated in basic medium (BM; 1% tryptone, 0.5%
yeast extract, 0.5% NaCl, 0.1% glucose, 0.1% K2HPO4)
with aliquots of overnight cultures and incubated at 37°C
until logarithmic phase was reached. In case of the com-
plemented mutant, BM was modified by replacing glucose
with 0.5% xylose to allow for expression of the plasmid-
encoded graRS genes [10].
The  graRS::erm/dltA::spc  double mutant was created by
bacteriophage  φ 11-mediated transduction of the
graRS::erm mutation into the dltA::spc deletion mutant.
To prepare bacteria for the mouse infection model, precul-
tures of the staphylococcal strains which were grown for 8
h in tryptic soy broth (TSB) were diluted 1:100 into fresh
TSB and incubated for 18 h without shaking.
Cytochrome c binding assay
Log-phase bacteria were harvested, washed twice with
potassium phosphate buffer containing 0.01% human
serum albumin (KPi buffer) and bacterial density was
adjusted to an OD600 of 3. Bacteria from 1.5 ml aliquots
were resuspended in 500 μl cytochrome c (Sigma) solu-
tion (0.5 mg/ml) in case of the wild type, the graRS
mutant and the complemented graRS mutant and 750 μl
cytochrome c (Sigma) solution (1 mg/ml) in case of the
dltA and the dltA/graRS double mutant, respectively, and
incubated at 37°C. In order to prevent bacterial sedimen-
tation, samples were vigorously shaken. After 15 min,
samples were centrifuged and the supernatant was assayed
photometrically at 410 nm.
Lipid analyses
Comparison of membrane lipid patterns by extraction of
polar lipids and subsequent thin-layer chromatography
was performed as recently described [11].
Inactivation assay with human defense peptide LL-37
Log-phase bacteria were harvested, washed twice with
potassium phosphate buffer containing 0.01% human
serum albumin (KPi buffer) and bacterial density was
adjusted to an OD600 of 1.5. Samples (40 μl) with a final
concentration of 20 μg/ml LL-37 were shaken at 37°C.
After 20 min, 160 μl ice-cold KPi buffer was added to
block further antimicrobial action and appropriate aliq-
uots were plated on BM agar plates. After 24 h incubation
at 37°C, CFU were enumerated.
Inactivation assay with human neutrophil granulocytes
Bacteria were grown to logarithmic phase, washed, and
adjusted in KPi buffer as described above. Neutrophils
were isolated from peripheral blood of healthy volunteers
by ficoll/histopaque gradient centrifugation as described
previously [26] and resuspended in HBSS-HSA (HBSS
containing 0.05% human serum albumin). Bacterial and
neutrophil suspensions were mixed to final concentra-
tions of 5 × 106/ml bacteria and 2.5 × 106/ml neutrophils.
Bacteria were opsonized by addition of pooled human
serum (Sigma) to a final concentration of 10%. Samples
(500 μl) were shaken at 37°C. After 15, 30 and 60 min,
aliquots were diluted in ice-cold water and vortexed vigor-
ously to disrupt the neutrophils and halt bacterial killing.
Appropriate dilutions were plated on BM agar plates and
incubated at 37°C for 24 h for enumeration of CFU.
Mouse infection model
All procedures involving animals were approved by the
UCSD Animal Care Committee, which serves to ensure
that all federal guidelines concerning animal experimen-
tation are met.
Female BALB/c mice (12 to 15 weeks old) were infected
intraperitoneally with S. aureus WT or the graRS mutant.
Briefly, precultures of the staphylococcal strains which
were grown for 8 h in tryptic soy broth (TSB) were diluted
1:100 into fresh TSB, incubated for 18 h without shaking,
washed twice in PBS, adjusted to 3 × 108 CFU/ml in PBS
and 400 μl of these suspensions were injected intraperito-
neally. 72 h after infection, mice were sacrificed, one kid-
ney was aseptically removed, weighed, homogenized, and
serially diluted in PBS for plating on Todd Hewitt agar
plates. After 24 h incubation at 37°C, the numbers of
CFU/kidney were determined.
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